Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity
about
A diverse array of genetic factors contribute to the pathogenesis of systemic lupus erythematosusHistone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis developmentPotential of epigenetic therapies in non-cancerous conditions.HDAC9 Inhibits Osteoclastogenesis via Mutual Suppression of PPARγ/RANKL Signaling.Histone deacetylation of memory T lymphocytes by You-Gui-Wan alleviates allergen-induced eosinophilic airway inflammation in asthma.Histone/protein deacetylases and T-cell immune responsesHDAC expression and activity is upregulated in diseased lupus-prone mice.Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes.Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.Histone deacetylase 3 regulates the inflammatory gene expression programme of rheumatoid arthritis fibroblast-like synoviocytesClass I and II histone deacetylase inhibition by ITF2357 reduces SLE pathogenesis in vivo.Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expressionHDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation.Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.T-cell-based immunotherapy of autoimmune diseases.Perspectives on epigenetic-based immune intervention for rheumatic diseases.Epigenetic dysregulation in systemic lupus erythematosus.Epigenetic-based immune intervention for rheumatic diseases.Class IIa HDACs - new insights into their functions in physiology and pathology.The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.ROQUIN signalling pathways in innate and adaptive immunity.Association between histone hyperacetylation status in memory T lymphocytes and allergen-induced eosinophilic airway inflammation.The acetyl code in rheumatoid arthritis and other rheumatic diseases.Translating epigenetics into clinic: focus on lupus.IRF5 is elevated in childhood-onset SLE and regulated by histone acetyltransferase and histone deacetylase inhibitors.Role of histone deacetylase 9 in regulating adipogenic differentiation and high fat diet-induced metabolic disease.Chemokine-Like Receptor 1 Is a Novel Wnt Target Gene that Regulates Mesenchymal Stem Cell Differentiation.Class I and II histone deacetylase expression in human chronic periodontitis gingival tissue.Saethre-Chotzen phenotype with learning disability and hyper IgE phenotype in a patient due to complex chromosomal rearrangement involving chromosomes 3 and 7
P2860
Q22299119-DFB3FA7C-CD0C-4C51-BA57-BDAD2AE055F7Q34440353-F8F63B17-C9D0-495A-94B1-24361D1B880AQ34742578-3D1843A3-0BEF-450C-90DB-C6117B21DFB5Q35555670-10395889-EFDB-427C-94D4-146FCE1AB92AQ35735323-C45CC1AA-9182-4FCF-88A9-87CB91A616E9Q35849307-043CEF82-F2F3-4239-AFD2-441EFBB938EAQ36338516-77B4625B-D796-4EB0-9E66-DC7CAC442433Q36729407-AAC2633F-BE6B-4469-803B-511E30060488Q37545385-03FCD266-8EB8-473E-B2F8-1C1E6EEFEFA3Q37604525-48B7C13E-9DD6-47B1-ABBC-617628BC262CQ37657613-610B5E02-5EDF-47CD-87D0-2C9107E312BBQ37679886-BCC92586-9650-401C-A583-BFC4DCE3A85AQ37949185-91FA5A4C-F27C-419D-996D-66B60BAB99FEQ38076074-E0F35300-284F-47C4-B5F6-E9610F85DAD3Q38089940-8A3800D6-89A4-457C-9FA4-33432BDB4F82Q38091122-2F022E64-0681-4545-A8FF-14C9F93544BEQ38152825-54902512-15FB-4602-B764-9AFF6ED15F1FQ38210478-C8F3A30A-0A61-4D95-B097-6AB9D980894CQ38253128-CFE46860-9E2F-46CE-88FC-98A5CAB8F213Q38260795-09D173D6-0EFF-4EE9-AACA-F27FD737CFB0Q38802693-40832040-9E6A-401D-92D8-CF2E40D576A0Q38893203-9AF8D094-67F5-45CC-AB92-04B56BAFC65DQ39094945-ECA78FE8-C7DE-45FD-A653-CC15DCCAD882Q41228881-DB2F8881-A791-48D2-84D0-A2EAC841E135Q41470976-6A0A6EA0-D8DD-4DD1-9B9A-610117EFBA4EQ42232167-74CF19EC-3AEB-49FF-97E6-5083CFE88244Q51402738-B02AA559-18C0-4A0E-B780-B085C621F964Q54161049-B5896D5A-F0FB-444B-86BD-6E4C77EF87DDQ56321207-62E2467D-7212-4F15-BBAE-0B12ABC5B9D5
P2860
Histone deacetylase 9 deficiency protects against effector T cell-mediated systemic autoimmunity
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Histone deacetylase 9 deficien ...... mediated systemic autoimmunity
@ast
Histone deacetylase 9 deficien ...... mediated systemic autoimmunity
@en
type
label
Histone deacetylase 9 deficien ...... mediated systemic autoimmunity
@ast
Histone deacetylase 9 deficien ...... mediated systemic autoimmunity
@en
prefLabel
Histone deacetylase 9 deficien ...... mediated systemic autoimmunity
@ast
Histone deacetylase 9 deficien ...... mediated systemic autoimmunity
@en
P2093
P2860
P356
P1476
Histone deacetylase 9 deficien ...... mediated systemic autoimmunity
@en
P2093
Benjamin A Garcia
Christopher M Reilly
Kailin Yan
Nicolas L Young
Nilamadhab Mishra
P2860
P304
28833-28843
P356
10.1074/JBC.M111.233932
P407
P577
2011-06-27T00:00:00Z